NMRA

Neumora Therapeutics, Inc.

11.20 USD
-0.08 (-0.71%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Neumora Therapeutics, Inc. stock is up 26.55% since 30 days ago. The next earnings date is Aug 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 July’s closed higher than June. 100% of analysts rate it a buy.

About Neumora Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our principal executive offices are located at 490 Arsenal Way, Suite 200, Watertown, Massachusetts.